A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Ductal Carcinoma In Situ
Interventions: BIOLOGICAL: Granulocyte-Macrophage Colony-Stimulating Factor|BIOLOGICAL: Multi-epitope HER2 Peptide Vaccine H2NVAC|PROCEDURE: Therapeutic Conventional Surgery|PROCEDURE: Echocardiography|PROCEDURE: Biospecimen Collection|PROCEDURE: Biopsy
Sponsor: Mayo Clinic